P-78: A Randomised Placebo-Controlled Trial to Determine the Effect of Iron Supplementation on Neonatal Outcome in Pregnant Women with Normal Heamoglobin (Hb=11-13

Background: To study the effect of iran supplementation on neonal outcom in pregnant women with normal heamoglobin (Hb=11g/dl )13 g/dl Methods : two handrad pregnant women with Hb=11-13 g/dl in the early slage of pregmancy? Materials and Methods: Each woman look one tablet of 50 mg of ferrossalphate daily in the case group (n=100) and placebo group (n=100). Results: While no significant differences in neonatal outcome hetmeen the two groups small for gestatnal age birth rate increased in the case group incompavison with contral group (13%) vs. (10.5%). Medambirth weight in case group was 3.150 kg vs. (3 kg) in control group. Conclusion: Our finding proves that rovtine ironsopplememtation in nonaneaic women is not recomemded.